Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Global

iShares Global Healthcare ETF

+ Add to Watchlist

IXJ:AU

146.1900 AUD 1.4100 0.97%

As of 01:46:24 ET on 05/29/2015.

Snapshot for iShares Global Healthcare ETF (IXJ)

Open: 145.8800 High - Low: 146.4000 - 145.7500 Primary Exchange: ASE
Volume: 10,515 52-Week Range: 98.5000 - 146.4000 Beta vs SGHNW: 0.8959

ETF Chart for IXJ

No chart data available.
  • IXJ:AU 146.1900
  • 1D
  • 1M
  • 1Y
144.7800
Interactive IXJ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IXJ

iShares Global Healthcare ETF is an exchange-traded fund incorporated in the USA. The ETF tracks the S&P Global Healthcare Index. The ETF holds global large- cap health care stocks. Its investments are focused in pharmaceutical, biotech, and medical device companies, with its largest allocation to the United States. A market capitalization methodology is used for weighting.

Inception Date: 2009-03-12 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / DIANE HSIUNG
Web Site: www.ishares.com

Fundamentals for IXJ

NAV -
Assets (M) (on 2015-05-28) 1,738.3281
Shares out (M) 9.15
Market Cap (M) 1,334.25
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for IXJ

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-22) 0.3858
Dividend Yield (ttm) 1.04%

Performance for IXJ

1-Month +3.57% 1-Year +46.04%
3-Month +4.70% 3-Year +37.44%
Year To Date +17.78% 5-Year +23.82%
Expense Ratio 0.48

Top Fund Holdings for IXJ

Filing Date: 05/27/2015
Name Position Value % of Total
Johnson & Johnson 1,106,976 111,948,483 6.471%
Novartis AG 1,077,336 111,514,918 6.445%
Pfizer Inc 2,439,840 83,686,512 4.837%
Roche Holding AG 279,864 82,553,410 4.772%
Merck & Co Inc 1,129,752 67,175,054 3.883%
Gilead Sciences Inc 592,176 66,596,113 3.849%
Bayer AG 328,848 48,960,728 2.830%
Sanofi 478,608 48,683,310 2.814%
Amgen Inc 302,016 48,455,447 2.801%
Actavis plc 155,065 47,572,391 2.750%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil